Epigenetic clocks in neurodegenerative diseases: a systematic review
Conclusions
Epigenetic clocks hold great potential in neurodegenerative diseases. Further research is encouraged to evaluate the clinical utility and promote the application.
PROSPERO registration number
CRD42022365233.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Yang, T., Xiao, Y., Cheng, Y., Huang, J., Wei, Q., Li, C., Shang, H. Tags: Neurodegeneration Source Type: research
More News: ALS | Alzheimer's | Brain | Databases & Libraries | Huntington's Disease | Neurology | Neuroscience | Neurosurgery | Parkinson's Disease | Pathology | Psychiatry | Science | Study